XML 42 R30.htm IDEA: XBRL DOCUMENT
v3.23.2

Stock-Based Compensation (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2023
Stock Settled Stock Appreciation Rights SARS [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Stock-Based Compensation Grant Details | In 2021, we granted SSSARs to various employees under the terms of the plan. The following table summarizes information relating to these grants:
|  |  |  |  | 2021
SSSARs granted |  |  |  |  | 124 |
Weighted average grant date fair value per right |  |  |  |  | $ | 36.24 |
Weighted average assumptions used in fair value calculations: |  |  |  |  |
Risk-free interest rate |  |  |  |  | 0.51 | %
Dividend yield |  |  |  |  | 1.69 | %
Volatility factor of the expected market price of our common stock |  |  |  |  | 28.63 | %
Expected life in years |  |  |  |  | 4.55
Compensation Expense And Tax Benefits Recorded | The following table summarizes our SSSARs compensation expense and tax benefits recorded for each of the years ended June 30:
| 2023 |  | 2022 |  | 2021
Compensation expense | $ | 1,972 |  |  | $ | 3,566 |  |  | $ | 3,568 |
Tax benefits | $ | 216 |  |  | $ | 749 |  |  | $ | 749 |
Intrinsic value of exercises | $ | 3,873 |  |  | $ | 317 |  |  | $ | 6,187 |
Fair Value Of Awards Vested | The total fair values of SSSARs vested for each of the years ended June 30 were as follows:
| 2023 |  | 2022 |  | 2021
Fair value of vested rights | $ | 2,611 |  |  | $ | 4,095 |  |  | $ | 3,404 |
Stock-Settled Stock Appreciation Rights Activity | The following table summarizes the activity relating to SSSARs granted under the plan for the year ended June 30, 2023:
| Number of Rights |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life in Years |  | Aggregate Intrinsic Value
Outstanding at beginning of year | 393 |  |  | $ | 158.12 |  |  |  |  |
Exercised | (225) |  |  | $ | 152.46 |  |  |  |  |
Granted | — |  |  | $ | — |  |  |  |  |
Forfeited | (13) |  |  | $ | 165.36 |  |  |  |  |
Outstanding at end of year | 155 |  |  | $ | 165.77 |  |  | 2.15 |  | $ | 5,463 |
Exercisable and vested at end of year | 122 |  |  | $ | 162.57 |  |  | 2.01 |  | $ | 4,709 |
Vested and expected to vest at end of year | 155 |  |  | $ | 165.77 |  |  | 2.15 |  | $ | 5,463 |
Stock-Settled Stock Appreciation Rights Outstanding By Grant Year | The following table summarizes information about the SSSARs outstanding by grant year at June 30, 2023:
|  | Outstanding |  | Exercisable
|  |  |  |  |  | Weighted Average |  |  |  |
Grant Years |  | Range of Exercise Prices |  | Number Outstanding |  | Remaining Contractual Life in Years |  | Exercise Price |  | Number Exercisable |  | Weighted Average Exercise Price
2021 |  | $167.18-$187.30 |  | 78 |  | 2.64 |  | $177.79 |  | 45 |  | $177.76
2020 |  | $153.71-$154.22 |  | 76 |  | 1.66 |  | $153.71 |  | 76 |  | $153.71
2019 |  | $154.48 |  | 1 |  | 0.66 |  | $154.48 |  | 1 |  | $154.48
Employee Restricted Stock [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Stock-Based Compensation Grant Details | In 2023, 2022 and 2021, we granted shares of restricted stock to various employees under the terms of the plan. The following table summarizes information relating to these grants:
| 2023 |  | 2022 |  | 2021
Employees |  |  |  |  |
Restricted stock granted | 29 |  |  | 30 |  |  | 17 |
Grant date fair value | $ | 4,448 |  |  | $ | 5,691 |  |  | $ | 2,918 |
Weighted average grant date fair value per award | $ | 154.80 |  |  | $ | 189.12 |  |  | $ | 177.89 |
Director Restricted Stock [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Stock-Based Compensation Grant Details | In 2023, 2022 and 2021, we also granted shares of restricted stock to our nonemployee directors under the terms of the plan. The following table summarizes information relating to each of these grants:
| 2023 |  | 2022 |  | 2021
Nonemployee directors |  |  |  |  |
Restricted stock granted | 4 |  |  | 5 |  |  | 4 |
Grant date fair value | $ | 919 |  |  | $ | 799 |  |  | $ | 774 |
Weighted average grant date fair value per award | $ | 203.34 |  |  | $ | 162.15 |  |  | $ | 172.89 |
Restricted Stock [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Compensation Expense And Tax Benefits Recorded | The following table summarizes our restricted stock compensation expense and tax benefits recorded for each of the years ended June 30:
| 2023 |  | 2022 |  | 2021
Compensation expense | $ | 4,432 |  |  | $ | 4,942 |  |  | $ | 3,558 |
Tax benefits | $ | 677 |  |  | $ | 1,038 |  |  | $ | 747 |
Fair Value Of Awards Vested | The total fair values of restricted stock vested for each of the years ended June 30 were as follows:
| 2023 |  | 2022 |  | 2021
Fair value of vested shares | $ | 4,996 |  |  | $ | 2,772 |  |  | $ | 3,148 |
Restricted Stock Activity | The following table summarizes the activity relating to restricted stock granted under the plan for the year ended June 30, 2023:
| Number of Shares |  | Weighted Average Grant Date Fair Value
Unvested restricted stock at beginning of year | 74 |  |  | $ | 172.27 |
Granted | 33 |  |  | $ | 161.40 |
Vested | (32) |  |  | $ | 156.89 |
Forfeited | (10) |  |  | $ | 171.29 |
Unvested restricted stock at end of year | 65 |  |  | $ | 174.62 |
Performance Units [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Stock-Based Compensation Grant Details | In 2023 and 2022, we granted performance units to various employees under the terms of the plan. The following table summarizes information relating to these grants:
| 2023 |  | 2022 |  |
Performance units granted | 26 |  |  | 20 |  |  |
Grant date fair value | $ | 4,572 |  |  | $ | 4,151 |  |  |
Weighted average grant date fair value per award | $ | 173.73 |  |  | $ | 201.67 |  |  |
Compensation Expense And Tax Benefits Recorded | The following table summarizes our performance units compensation expense and tax benefits recorded for each of the years ended June 30:
| 2023 |  | 2022 |  |
Compensation expense | $ | 2,678 |  |  | $ | 1,055 |  |  |
Tax benefits | $ | 355 |  |  | $ | 222 |  |  |
Performance Units Grant Date Valuation Assumptions | For our performance units with a market condition, the grant-date fair value is estimated using a Monte Carlo simulation. The assumptions used in the Monte Carlo simulation were as follows:
| 2023 |  | 2022 |  |
Risk-free interest rate | 3.18 | % |  | 0.41 | % |  |
Dividend yield | 2.08 | % |  | 1.65 | % |  |
Volatility factor of the expected market price of our common stock | 32.20 | % |  | 31.30 | % |  |
Performance Units Activity | The following table summarizes the activity relating to performance units granted under the plan for the year ended June 30, 2023:
| Number of Units |  | Weighted Average Grant Date Fair Value
Unvested performance units at beginning of year | 19 |  |  | $ | 201.65 |
Granted | 26 |  |  | $ | 173.73 |
Vested | — |  |  | $ | — |
Forfeited | (5) |  |  | $ | 186.60 |
Unvested performance units at end of year | 40 |  |  | $ | 185.39 |

X
- Definition ScheduleOfShareBasedCompensationFairValueOfAwardsVested + References No definition available. + Details
Name: | lanc_ScheduleOfShareBasedCompensationFairValueOfAwardsVestedTableTextBlock
Namespace Prefix: | lanc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of grant details related to stock-based compensation awards, including the number of awards granted and the fair value. + References No definition available. + Details
Name: | lanc_ScheduleOfShareBasedCompensationGrantDetailsTableTextBlock
Namespace Prefix: | lanc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of stock-settled stock appreciation rights exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under the SARs, weighted average exercise price and remaining contractual SARs terms. + References No definition available. + Details
Name: | lanc_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockPlansByExercisePriceRangeTextBlock
Namespace Prefix: | lanc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of share-based payment awards, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References No definition available. + Details
Name: | lanc_ScheduleOfShareBasedPaymentAwardValuationAssumptionsTableTextBlock
Namespace Prefix: | lanc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=lanc_EmployeeRestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=lanc_DirectorRestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |